Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
24 studies found for:    " October 10, 2007":" November 09, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" October 10, 2007":" November 09, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed A Controlled Study of the Safety and Efficacy of Lessertia Frutescens in HIV-infected South African Adults
Condition: HIV Infections
Interventions: Drug: Placebo;   Drug: Low Dose;   Drug: Mid Dose;   Drug: High Dose
2 Completed
Has Results
Acupuncture and Relaxation Response for GI Symptoms and HIV Medication Adherence
Condition: HIV Infections
Interventions: Procedure: Acupuncture;   Behavioral: Relaxation Response;   Other: sham acupuncture
3 Completed
Has Results
Rapid HIV Testing Program in the Emergency Department
Condition: HIV Infections
Intervention: Other: HIV test by oral swab
4 Completed
Has Results
Efficacy Study of Substitution of Darunavir/Ritonavir (DRV/r) for Dual-boosted Protease Inhibitors
Condition: HIV Infections
Interventions: Drug: Darunavir (DRV/r);   Drug: continue on current dual boosted PI
5 Completed Study of a Potential Preventive Vaccine Against HIV in Healthy Volunteers
Condition: HIV Infections
Interventions: Device: TriGrid™ Delivery System;   Device: conventional intramuscular injection
6 Completed Impact of MK-0518 (Raltegravir) Intensification on HIV-1 Viral Latency in Patients With Previous Complete Viral Suppression
Condition: HIV Infections
Intervention: Drug: MK-0518 400mg twice a day
7 Recruiting The Role of Diet Education and Nutritional Counselling in the Ongoing Care of People Living With HIV in Thailand
Condition: HIV Infections
Intervention: Behavioral: Nutrition Counselling
8 Completed
Has Results
TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors
Conditions: HIV Infections;   HIV-1
Interventions: Drug: TMC278;   Drug: efavirenz
9 Completed Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects (Study P04875)
Condition: HIV Infections
Interventions: Drug: Vicriviroc;   Drug: emtricitabine and tenofovir disoproxil fumarate
10 Completed Correlation Between Intestinal Parasites and Serum Level of Eosinophils and IgE in Individuals With HIV or AIDS
Condition: HIV Infections
Intervention:
11 Completed Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment
Condition: HIV Infections
Interventions: Drug: lamivudine, abacavir , ritonavir, atazanavir;   Drug: emtricitabine, tenofovir, ritonavir, atazanavir
12 Completed Motivation and Patch Treatment for HIV-Positive Smokers
Conditions: HIV Infections;   Smoking Cessation
Interventions: Behavioral: Standard Care;   Behavioral: Motivational Enhancement
13 Completed Incidence and Severity of Neuropsychiatric Adverse Events of Efavirenz Given as a Stepped Dosage vs. the Usual Dosage
Conditions: HIV-1 Infection;   HIV Infection
Intervention: Drug: Efavirenz
14 Completed Reducing Sex-Related HIV Risk Behaviors in Patients Receiving Treatment for Opioid Dependence
Conditions: Opiate Dependence;   HIV Infections
Interventions: Behavioral: Enhanced Sexual Risk Management;   Behavioral: Standard Sexual Risk Management
15 Completed
Has Results
Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples
Conditions: HIV-1 Infections;   HIV Infections
Interventions: Drug: Tenofovir Disoproxil Fumarate (TDF);   Drug: Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF);   Drug: Placebo
16 Completed Safety and Effectiveness of 3 Doses of Crofelemer Compared to Placebo in the Treatment of HIV Associated Diarrhea
Condition: HIV Associated Diarrhea
Interventions: Drug: Crofelemer 125 mg;   Drug: Crofelemer 250 mg;   Drug: Crofelemer 500 mg;   Drug: Placebo
17 Completed Utilization of HIV Clinical Services in Rural India
Conditions: HIV Infections;   Sexually Transmitted Infections
Intervention: Behavioral: HIV Testing and Care Services
18 Completed Vicriviroc in HIV(R5/X4)-Treatment Experienced Subjects (Study P05057AM5)(COMPLETED)
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Interventions: Drug: Vicriviroc;   Drug: Placebo
19 Completed
Has Results
KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects
Conditions: Infection, Human Immunodeficiency Virus I;   HIV Infection
Interventions: Drug: Abacavir/lamivudine and efavirenz;   Drug: Tenofovir/Emtricitabine and efavirenz
20 Completed Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-coinfected Patients
Conditions: Hepatitis C, Chronic;   HIV Infections
Interventions: Drug: Pegylated interferon alfa-2a and Ribavirin;   Drug: Pegylated interferon alfa 2a and Ribavirin

   Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.